Related Experiment Video
Updated: Jul 4, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
PRES following administration of DHE in a patient with unsuspected pheochromocytoma
Brendan J Kelley1, Stephen Samples, Robert Kunkel
1Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Abstract:
We describe neurological complications which manifested after a patient with unsuspected pheochromocytoma was administered dihydroergotamine. Following administration of dihydroergotamine, the patient developed Balint syndrome, with the appearance of symmetric, bilateral occipital signal change on magnetic resonance imaging suggestive of posterior reversible encephalopathy syndrome.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Depolarizing Blockers: Pharmocokinetics
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Cushing Syndrome I: Introduction
Direct-Acting Cholinergic Agonists: Therapeutic Uses

